A. Rosas

Pegylated recombinant interferon alpha-2b vs recombinant interferon alpha-2b for the initial treatment of chronic-phase chronic myelogenous leukemia: a phase III study

R. Silver, C. Tendler, M. Michallet, 2004, Leukemia.

Transforming growth factor beta and platelets in allergic rhinitis and sinusitis.

G. Rico, G. Vega, A. Rosas, 2011, Revista alergia Mexico.

GM-CSF instead of hematological support during high-dose chemotherapy for refractory malignant lymphoma.

A. Avilés, M. Nambo, A. Talavera, 1995, Leukemia & lymphoma.

GM-CSF Instead of Hematological During High-Dose Chemotherapy for Malignant Lymphoma Support Refractory

A. Avilés, M. Nambo, A. Talavera, 1995 .

Combined therapy for angioimmunoproliferative lesions.

A. Avilés, M. Nambo, S. Delgado, 1994, European journal of cancer. Part B, Oral oncology.

Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study.

R. Figueroa-Damián, J. Arredondo-García, C. Amábile-Cuevas, 2004, The Journal of antimicrobial chemotherapy.

Alternating combination chemotherapy and interferon improves survival in poor prognosis multiple myeloma.

A. Avilés, A. Talavera, S. Delgado, 1995, Clinical oncology (Royal College of Radiologists (Great Britain)).

Dexamethasone, all trans retinoic acid and interferon alpha 2a in patients with refractory multiple myeloma.

A. Avilés, S. Cleto, J. Huerta‐Guzmán, 1999, Cancer biotherapy & radiopharmaceuticals.